Np mrd loader

Record Information
Version1.0
Created at2021-01-06 08:49:20 UTC
Updated at2021-07-15 17:42:41 UTC
NP-MRD IDNP0023780
Secondary Accession NumbersNone
Natural Product Identification
Common NameRP-66453
Provided ByNPAtlasNPAtlas Logo
Description RP-66453 is found in Streptomyces sp. and Streptomyces sp. A 9738. It was first documented in 1998 (PMID: 9666181). Based on a literature review very few articles have been published on RP-66453 (PMID: 31800136) (PMID: 14502745).
Structure
Thumb
Synonyms
ValueSource
RP 66453, Secondary peptideMeSH
14-Amino-17-(butan-2-yl)-9,15,18,21,32-pentahydroxy-2-oxa-16,19,22-triazapentacyclo[23.2.2.1,.1,.1,]dotriaconta-1(27),3,5,7(32),8,10,12(31),15,18,21,25,28-dodecaene-23-carboxylateGenerator
Chemical FormulaC33H36N4O8
Average Mass616.6710 Da
Monoisotopic Mass616.25331 Da
IUPAC Name(14S,17S,20S,23R)-14-amino-17-[(2R)-butan-2-yl]-9,32-dihydroxy-15,18,21-trioxo-2-oxa-16,19,22-triazapentacyclo[23.2.2.1^{3,7}.1^{5,20}.1^{8,12}]dotriaconta-1(27),3(32),4,6,8(31),9,11,25,28-nonaene-23-carboxylic acid
Traditional Name(14S,17S,20S,23R)-14-amino-17-[(2R)-butan-2-yl]-9,32-dihydroxy-15,18,21-trioxo-2-oxa-16,19,22-triazapentacyclo[23.2.2.1^{3,7}.1^{5,20}.1^{8,12}]dotriaconta-1(27),3(32),4,6,8(31),9,11,25,28-nonaene-23-carboxylic acid
CAS Registry NumberNot Available
SMILES
CCC(C)C1NC(=O)C(N)CC2=CC(=C(O)C=C2)C2=CC3=CC(OC4=CC=C(CC(NC(=O)C(C3)NC1=O)C(O)=O)C=C4)=C2O
InChI Identifier
InChI=1S/C33H36N4O8/c1-3-16(2)28-32(42)35-24-14-19-11-22(21-10-18(6-9-26(21)38)12-23(34)30(40)37-28)29(39)27(15-19)45-20-7-4-17(5-8-20)13-25(33(43)44)36-31(24)41/h4-11,15-16,23-25,28,38-39H,3,12-14,34H2,1-2H3,(H,35,42)(H,36,41)(H,37,40)(H,43,44)
InChI KeyLRYMXYNLAMRRTH-UHFFFAOYSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Streptomyces sp.NPAtlas
Streptomyces sp. A 9738Bacteria
Chemical Taxonomy
ClassificationNot classified
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP0ALOGPS
logP0.44ChemAxon
logS-4.2ALOGPS
pKa (Strongest Acidic)3.16ChemAxon
pKa (Strongest Basic)7.52ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count7ChemAxon
Polar Surface Area200.31 ŲChemAxon
Rotatable Bond Count3ChemAxon
Refractivity163.07 m³·mol⁻¹ChemAxon
Polarizability64.16 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
NPAtlas IDNPA002944
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID8092670
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound9917023
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Helynck G, Dubertret C, Frechet D, Leboul J: Isolation of RP 66453, a new secondary peptide metabolite from Streptomyces sp. useful as a lead for neurotensin antagonists. J Antibiot (Tokyo). 1998 May;51(5):512-4. doi: 10.7164/antibiotics.51.512. [PubMed:9666181 ]
  2. Ben-Lulu M, Gaster E, Libman A, Pappo D: Synthesis of Biaryl-Bridged Cyclic Peptides via Catalytic Oxidative Cross-Coupling Reactions. Angew Chem Int Ed Engl. 2020 Mar 16;59(12):4835-4839. doi: 10.1002/anie.201913305. Epub 2020 Jan 30. [PubMed:31800136 ]
  3. Bois-Choussy M, Cristau P, Zhu J: Total synthesis of an atropdiastereomer of RP-66453 and determination of its absolute configuration. Angew Chem Int Ed Engl. 2003 Sep 15;42(35):4238-41. doi: 10.1002/anie.200351996. [PubMed:14502745 ]